| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 453,183 | 384,470 | 307,361 | 919,037 | | Cost of Revenue | 414,575 | 376,810 | 290,958 | 992,602 | | | Gross Profit | 38,608 | 7,660 | 16,403 | (73,565) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 82,224 | 73,388 | 62,035 | 122,285 | | Non Recurring |
-
|
-
|
-
| 43,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (43,616) | (65,728) | (45,632) | (239,250) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,830 | 1,766 | 3,513 | 2,792 | | Earnings Before Interest And Taxes | (61,669) | (72,112) | (50,920) | (292,984) | | Interest Expense | 15,379 | 11,471 | 8,652 |
-
| | Income Before Tax | (77,048) | (83,583) | (59,572) | (292,984) | | Income Tax Expense | (11,000) | (5,200) | (1,500) | 14,300 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (66,048) | (78,383) | (58,072) | (307,284) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (66,048) | (78,383) | (58,072) | (307,284) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($66,048) | ($78,383) | ($58,072) | ($307,284) |
|
0.29% Nasdaq 
Income Statement
